Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacological Management of Delirium (PMD)
This study is currently recruiting participants.
Study NCT00842608   Information provided by National Institute on Aging (NIA)
First Received: February 10, 2009   Last Updated: March 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Delirium
Cognitive Impairment
Additional conditions recognized in this trial
Cognition Disorders
More general conditions related to this trial
Confusion
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Reduced exposure to benzodiazepines
Haloperidol
Usual care
Additional drug interventions recognized in this trial
Cholinergic Antagonists
Haloperidol decanoate
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiemetics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Cholinergic Agents
Dopamine Agents
Dopamine Antagonists
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute on Aging (NIA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services